Saturday 17 October 2026
Export QTI’s income statement to Excel — free account
QT Imaging Holdings, Inc.
QTI Healthcare Medical Devices
QT Imaging Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.9 million, up 287.9% from fiscal 2024. In the quarter to June 2026, revenue grew 103.2%, EPS fell 78.6%, free cash flow fell 236.3% and total debt rose 286.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.41
0.03
+1.26%
Follow QTI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | — | — |
Altman Z-Score |
0.02 | (12.24) | 19.55 | — | — |
P/S ratio |
3.38 | 9.99 | 12,942.56 | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(4.34) | (36.45) | (16.58) | — | — |
Beneish M-Score |
17.42 | 101.74 | — | — | — |
P/Operating CF |
(20.60) | (39.74) | (764.88) | — | — |
P/B ratio |
9.92 | 0.00 | 0.00 | — | — |
Price to Tangible BV |
9.98 | 0.00 | 0.00 | — | — |
EV/Sales |
3.07 | 11.56 | 13,121.68 | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
(6.48) | (5.62) | (200.46) | — | — |
EV/FCF |
(6.35) | (5.58) | (199.48) | — | — |
Quick Ratio |
2.06 | 0.13 | 0.03 | 0.02 | 0.67 |
Current Ratio |
2.81 | 0.50 | 0.66 | 0.06 | 1.83 |
Net Debt/EBITDA |
1.36 | (0.64) | (1.60) | (0.37) | 0.32 |
Debt/Assets |
19.93% | 145.29% | 110.92% | 3.92% | 0.03% |
Debt/Equity |
0.71 | (0.93) | (1.40) | (0.13) | (0.01) |
Asset Turnover |
1.30 | 0.76 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.42 | 0.71 | 0.43 | 0.32 | 1.23 |
Capex/Depreciation |
(0.95) | (0.38) | (0.03) | 0.00 | — |
Interest Coverage |
(1.68) | (2.71) | (9.19) | (185.24) | (180.22) |
| 1,363.27% | 190.85% | 66.32% | 35.62% | 0.00% | |
| (144.86%) | (221.53%) | (25.07%) | (2.84%) | 0.00% | |
ROIC |
(486.51%) | 0.00% | (161.15%) | 0.00% | 0.00% |
Return on Tangible Assets |
(144.99%) | 302.73% | 300.70% | 99.55% | (210.51%) |
Average Days of Receivables |
111.50 | 5.01 | 11.75 | — | — |
Research and Development Expense of Revenue |
20.80% | 66.96% | 3,677.23% | — | — |
Selling, General and Administrative Expense of Revenue |
48.01% | 236.73% | 8,484.41% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4.23% | 5.94% | 1,755.94% | 0.00% | 0.00% |
Graham Net Nets |
0.09 | (0.22) | (0.01) | — | — |
Graham Number |
0.00 | 8.03 | 8.49 | — | — |
Earnings Yield |
(35.90%) | (27.36%) | (1.16%) | — | — |
Free Cash Flow Yield |
(14.30%) | (20.74%) | (0.51%) | — | — |
Revenue per Share |
1.81 | 0.73 | 0.01 | 0.00 | 0.00 |
Operating CF per Share |
(0.86) | (1.51) | (0.83) | (0.58) | (0.50) |
Capex per Share |
(0.01) | (0.01) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.87) | (1.52) | (0.84) | (0.58) | (0.50) |
Cash per Share |
1.00 | 0.18 | 0.06 | 0.04 | 0.15 |
Shareholders Equity per Share |
0.62 | (1.43) | (1.67) | (6.00) | (3.27) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.62 | (1.43) | (1.67) | (6.00) | (3.27) |
Free Cash Flow |
(9.08) | (10.12) | (2.66) | (1.26) | (1.37) |
Working Capital |
14.22 | (4.88) | (2.52) | (3.94) | 0.53 |
Capital Expenditures |
(0.12) | (0.09) | (0.01) | — | — |
Net Current Asset Value |
5.52 | (10.71) | (7.20) | (54.77) | (241.39) |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.01 | 0.02 | 0.32 | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — |
| Other line items | |||||
Depreciation/Fixed assets |
0.41 | 1.18 | 0.98 | 0.00 | — |
Cash ROIC |
(42.26%) | (2,032.33%) | (115.24%) | 11.11% | 16.26% |
Accounts Receivable Turnover |
6.47 | 142.87 | 0.00 | — | — |
Accounts Payable Turnover |
4.72 | 2.07 | 0.17 | 0.00 | — |
Inventory Turnover |
2.53 | 0.59 | 0.00 | — | — |
Average Days of Payables |
126.36 | 130.90 | 3,664.87 | 0.00 | 0.00 |
Days of Inventory on Hand |
177.44 | 512.04 | 11,945.50 | — | — |
Average Receivables |
2.92 | 0.03 | — | — | — |
Average Payables |
2.19 | 1.08 | 0.78 | 0.11 | — |
Average Inventory |
4.08 | 3.78 | — | — | — |
Average Assets |
14.55 | 6.40 | 24.33 | 137.79 | — |
Average Common Equity |
(1.55) | (7.43) | (9.20) | (11.00) | — |
Columns are period end dates